SLU-PP-332 Pharmacokinetics
SLU-PP-332 half-life, absorption, routes of administration, and clearance.
Not Established in Humans
No human pharmacokinetic study — absorption, half-life, clearance — has been published for SLU-PP-332. Notably, the original compound required injection to show effects in mice, which is part of what motivated development of the orally-active follow-on compound, SLU-PP-915.
Physicochemical and PK profile
- Storage
- Store the lyophilized vial refrigerated (2-8°C) or at -20°C, away from light. Once reconstituted, keep refrigerated at 2-8°C and use promptly.
References
- SLU-PP-332 pan-ERR agonist metabolic syndrome study · Billon C, et al. · 2024